Why Atrion Corporation’s (ATRI) Stock Is Up 5.98%

By Jenna Brashear
March 02, 2023
Featured Tickers:
ATRI

One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Atrion Corporation before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Atrion Corporation’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Atrion Corporation’s stock price such as:

  • Current stock price and volume
  • Stock price history
  • Upgrades and downgrades from analysts
  • Stock price momentum as measured by its relative strength

About Atrion Corporation (ATRI)

Before we jump into Atrion Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Atrion Corporation is engaged in the development and manufacture of products primarily for medical applications. The Company's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. It has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The Company's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. It also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.

Want to learn more about Atrion Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Atrion Corporation. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Learn More About A+ Investor

Atrion Corporation’s Stock Price as of Market Close

As of March 02, 2023, 4:00 PM CST, Atrion Corporation’s stock price was $598.80.

Atrion Corporation is up 5.98% from its previous closing price of $565.00.

During the last market session, Atrion Corporation’s stock traded between $554.03 and $566.03. Currently, there are 1.77 million shares of Atrion Corporation stock available for purchase.

Atrion Corporation’s price-earnings (P/E) ratio is currently at 38.0, which is high compared to the Medical Equipment, Supplies & Distribution industry median of 33.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Atrion Corporation Stock Price History

Atrion Corporation’s (ATRI) price is currently up 5.42% so far this month.

During the month of March, Atrion Corporation’s stock price has reached a high of $598.80 and a low of $554.03.

Over the last year, Atrion Corporation has hit prices as high as $783.80 and as low as $534.99. Year to date, Atrion Corporation’s stock is down 15.05%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Atrion Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 01, 2023, there were analysts who downgraded Atrion Corporation’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Atrion Corporation’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Atrion Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Atrion Corporation (ATRI) by visiting AAII Stock Evaluator.

Relative Price Strength of Atrion Corporation

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of March 01, 2023, Atrion Corporation has a weighted four-quarter relative price strength of -3.71%, which translates to a Momentum Score of 35 and is considered to be Weak.

Want to learn more about how Atrion Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Atrion Corporation Stock Price: Bottom Line

As of March 2, 2023, Atrion Corporation’s stock price is $598.80, which is up 5.98% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Atrion Corporation’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.